首页> 外文OA文献 >Evaluation of Safety of FOLFOX4 Regimen in Patients with Advanced and Recurrent Colorectal Cancer

【2h】

Evaluation of Safety of FOLFOX4 Regimen in Patients with Advanced and Recurrent Colorectal Cancer

机译：先进和复发结直肠癌患者Folfox4方案的安全性评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tomoaki Yoshimura; Michio Kimura; Mina Iwai; Eiseki Usami; Toshiya Nakao; Tadashi Yasuda;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 444 A phase I/II study of oblimersen sodium in combination with oxaliplatin, 5-FU and leucovorin (FOLFOX4 regimen) in patients with advanced colorectal cancer [J] . C.Mita, M.Goldston, J.Kuhn, European Journal of Cancer Supplements . 2004,第8期

机译：444奥利美森钠联合奥沙利铂，5-FU和亚叶酸钙（FOLFOX4方案）在晚期大肠癌患者中进行的I / II期研究
2. The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer [J] . Jun Jia, Pengfei Zhang, Miaomiao Gou, Disease markers . 2019,第Pta1期

机译：血清CEA和Ca19-9在用西司昔单抗与Folfox4或Folfiri联合的患者的疗效评估和无进展生存预测的作用作为晚期结直肠癌的一线治疗
3. The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer [J] . Jun Jia, Pengfei Zhang, Miaomiao Gou, Disease markers . 2019,第2a3期

机译：血清CEA和CA19-9在用西司昔单抗与Folfox4或Folfiri合并作为晚期结直肠癌的一线治疗的患者的疗效评估中的作用和无进展生存预测
4. The Efficacy and Feasibility of 2-week Regimen of TS-1 for Advanced or Recurrent Gastric Cancer [C] . Y. Kimura, S. Iijima, T. Kato, International Gastric Cancer Congress . 2005

机译：2周TS-1治疗晚期或经常性胃癌的疗效和可行性
5. Evaluation of the accuracy of quantitative models in predicting Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) mutations in a population-based sample of early-onset colorectal cancer patients [D] . Carpiniello, Lauren 2007

机译：在以人群为基础的早发性大肠癌患者样本中预测定量模型预测Lynch综合征（遗传性非息肉病性大肠直肠癌，DNA失配修复缺陷）的准确性
6. The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer [O] . Jun Jia, Pengfei Zhang, Miaomiao Gou, 2019

机译：血清CEA和CA19-9在西妥昔单抗联合FOLFOX4或FOLFIRI作为晚期大肠癌一线治疗的患者的疗效评估和无进展生存期预测中的作用
7. The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer [O] . Jun Jia, Pengfei Zhang, Miaomiao Gou, 2019

机译：血清CEA和CA19-9在用西司昔单抗与Folfox4或Folfiri合并作为晚期结直肠癌的一线治疗的患者的疗效评估中的作用和无进展生存预测

Evaluation of Safety of FOLFOX4 Regimen in Patients with Advanced and Recurrent Colorectal Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅